
China Approves Inpegsomatropin Injection for Children with Growth Hormone Deficiency
China’s National Medical Products Administration (NMPA) has officially approved Inpegsomatropin Injection, a first-in-class, innovative long-acting…

China’s National Medical Products Administration (NMPA) has officially approved Inpegsomatropin Injection, a first-in-class, innovative long-acting…

China’s pharmaceutical market is growing rapidly and has become one of the world’s largest and…

✨ China has become one of the world’s largest pharmaceutical manufacturing and export hubs. With…

In recent years, the global pharmaceutical landscape has undergone a dramatic shift—one where China’s pharmaceutical…

The healthcare system in China is undergoing rapid transformation, and the China pharmaceutical distributor is…

With its pharmaceutical innovation engine roaring, China has become a premier destination to buy medicine in…

The National Medical Products Administration (NMPA) has officially approved the Class 1 innovative drug Trastuzumab…

Gone are the days of waiting in long queues at hospitals or visiting local drugstores…

In the critical world of healthcare procurement, the choice of a pharmaceutical distributor is a…

The China drug market—once known mainly for its generics and large-scale manufacturing—has evolved into a…